Pharmacokinetics of Ketoprofen in Patients with Chronic Renal Failure
Overview
Authors
Affiliations
The pharmacokinetics of ketoprofen were studied in 7 volunteers and in 5 patients suffering from varying degrees of renal insufficiency. All the subjects received a single oral dose (50 mg) of ketoprofen. Plasma concentrations were measured up to 24 hours after administration and urinary excretion for 2 days. Ketoprofen concentrations were determined by mass-fragmentography with a minimum level of detection of 0.02 mg/l. As expected, a reduction of the [51Cr]EDTA clearance was correlated with an increase in the elimination half-life of ketoprofen. The urinary excretion corresponded to results reported by other groups.
Pharmacokinetics and dosage adjustment in patients with renal dysfunction.
Verbeeck R, Musuamba F Eur J Clin Pharmacol. 2009; 65(8):757-73.
PMID: 19543887 DOI: 10.1007/s00228-009-0678-8.
Grubb N, Rudy D, Brater D, Hall S Br J Clin Pharmacol. 1999; 48(4):494-500.
PMID: 10583018 PMC: 2014373. DOI: 10.1046/j.1365-2125.1999.00046.x.
Hayball P, Nation R, Bochner F, Sansom L, Ahern M, Smith M Br J Clin Pharmacol. 1993; 36(3):185-93.
PMID: 9114902 PMC: 1364636. DOI: 10.1111/j.1365-2125.1993.tb04215.x.
Heintz R Drug Saf. 1995; 12(2):110-9.
PMID: 7766336 DOI: 10.2165/00002018-199512020-00004.
Reduced elimination of ketoprofen in the elderly is not necessarily due to impaired glucuronidation.
Verbeeck R, Wallace S, Loewen G Br J Clin Pharmacol. 1984; 17(6):783-4.
PMID: 6743473 PMC: 1463419. DOI: 10.1111/j.1365-2125.1984.tb02421.x.